EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+3.26%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$796M
AUM Growth
+$796M
(+2%)
Cap. Flow
+$3.29M
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
1
Reduced
–
Closed
2
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$93.8M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$88.9M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$1.58M |
Sector Composition
| 1 | Healthcare | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $624M | 78.43% | 1,146,979 +172,338 | +18% | +$93.8M |
|
2
iShares MSCI India ETF
INDA
$9.17B
| $135M | 17% | 2,425,144 | – | – |
|
3
Foghorn Therapeutics
FHTX
$286M
| $9.05M | 1.14% | 1,573,761 | – | – |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $7M | 0.88% | 989,410 | – | – |
|
5
Alector
ALEC
$238M
| $5.94M | 0.75% | 1,307,858 | – | – |
|
6
PMV Pharmaceuticals
PMVP
$74.2M
| $4.26M | 0.53% | 2,627,643 | – | – |
|
|
ME
7
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $4.01M | 0.5% | 10,243,122 | – | – |
|
8
Tenaya Therapeutics
TNYA
$184M
| $3.15M | 0.4% | 1,015,705 | – | – |
|
9
RAPT Therapeutics
RAPT
$188M
| $2.01M | 0.25% | 657,899 | – | – |
|
10
Surrozen
SRZN
$104M
| $960K | 0.12% | 87,696 | – | – |
|
|
11
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $2.84K | ﹤0.01% | 170,833 | – | – |
|
|
12
SPDR Gold Trust
GLD
$107B
| – | – | -432,271 | Closed | -$88.9M |
|
|
NGM
13
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – | -992,168 | Closed | -$1.58M |
|